Boots To Offer Medical Cannabis To Patients With Chronic Pain And Anxiety

Boots To Offer Medical Cannabis To Patients With Chronic Pain And Anxiety

Boots Becomes First UK Pharmacy Chain To Prescribe Medical Cannabis

Boots is to start prescribing medicinal cannabis in a first for a UK high street pharmacy chain. The retailer, which operates more than 1,800 stores across the country, will offer the drug through a new online cannabis service known as SureLeaf.

Patients suffering from chronic pain, anxiety or insomnia will be eligible for treatment. Medical cannabis was legalised in Britain eight years ago but has been tightly restricted by the NHS since then.

The service will operate privately rather than through the NHS. The NHS rarely prescribes the drug and offers it only to people with cancer, severe forms of epilepsy or multiple sclerosis.

Patients aged 25 and over will be eligible for a prescription. However, they must first have tried conventional medicines without obtaining adequate relief.

The move is likely to significantly expand availability of the drug, with people suffering from conditions including arthritis, sciatica, chronic back pain, migraines and endometriosis-related pain all eligible for a prescription.

How The SureLeaf Service Will Work

Patients will complete an online assessment before attending a video consultation with a specialist doctor. Any proposed prescription must then be approved by a separate medical team, including a second consultant, before treatment begins.

Patients will also be monitored regularly, with an initial review after 28 days and further appointments at least every three months.

Dr David Gwynne, the medical director of Boots Online Doctor, said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.”

Jamie Kerruish, Boots’ chief healthcare officer, said millions of people were living with pain that conventional treatments had failed to relieve. He said: “Medical cannabis is a specialist area of healthcare and, through SureLeaf, we’re giving eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care.”

Founded in 1849, Boots is one of Britain’s best-known high-street retailers. Last month it was sold to the billionaire Weston family from Canada for £6.7bn.

Legal Background And Restrictions

Medicinal cannabis was legalised in Britain in 2018 following campaigns by families of children suffering from severe epilepsy. However, patients were only able to obtain supplies via prescription from a specialist doctor.

Recreational cannabis remains illegal and is classified as a Class B drug. Possession carries a maximum sentence of five years in prison.

The new Boots service marks the first time a UK pharmacy chain has offered medical cannabis to patients.

Eligible patients must be 25 or older and complete both an online assessment and a video consultation with a registered doctor.

The service is expected to broaden access for patients whose conditions have not responded to conventional treatments.

Related Stories

Friday
administrator
Friday is a San Diego based writer covering cannabis news, culture, and business. Known for sharp analysis and clean reporting, Friday helps readers navigate the industry without the fluff. Every article is built on research, real sources, and a deep commitment to the cannabis community.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *